Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Syntocinon for Female Sexual Dysfunction in Menopause
NCT02229721Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Jun 2012
- Primary completion
- Oct 2013
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin nasal spray in female sexual dysfunction (FSD) (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Female Sexual Function at 22 weeks. Started Jun 2012; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
female sexual dysfunction (FSD)
Beyond the preview
Go deeper on NCT02229721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02229721.